02.29.24 OMA Board Book
OMA 2024
OMA Board of Trustees Meeting Book let
February 29, 2024 CONFIDENTIAL CONTENT – DO NOT SHARE CONTENT S OUTSIDE OMA
Board of Trustees (BOT) Meeting February 29, 2024 6:00 - 7:00 PM ET
Zoom Information: https://obesitymedicine-org.zoom.us/j/81711003852?pwd=yoNLIafobuaTIpeIFunwmlabN1fXKQ.1 Meeting ID: 817 1100 3852 Passcode: 147635 Dial-In Information: 719-359-4580; 81711003852#
Presiding Officer: Dr. Angela Fitch
Time
Topic
Lead Fitch
Action
Page
6:00 PM 6:02 PM 6:03 PM 6:05 PM 6:08 PM
Call to Order and Opening Remarks
Roll Call
Censani
Approval of the Agenda
Fitch Fitch Fitch
Vote
2
Conflict of Interest Disclosures
Discussion
6 - 14
Approval of the Consent Agenda and Supporting Documents Welcome to Newly Appointed BOT Member: Dr. Tiffany Lowe-Clayton Seating of the BOT Nominees for 2024 Elections Selection of the 2024 MFOMA Recipients Finalization of the 2024 OMA’s Ethics Committee Call to Adjourn and Closing Remarks
Vote
15 - 32
6:10 PM
Fitch
Discussion
6:15 PM
Alexander
Vote
33
6:30 PM
Alexander
Vote
34 - 37
6:40PM
Alexander
Vote
38 - 44
6:50 PM
Fitch
Rules of Order Policy Board Approved September 2017
Rules of Order for Board Meetings Quorum: Our bylaws state that a quorum is present if the majority of the board is present.
Order of the day: Each meeting will have an agenda which will include points to discuss, old business and new business. The leader of the meeting is referred to as the “Chair.” This may be the chairman of the board, the president, or the highest-ranking officer present at the meeting. Items to discuss: All board members may submit items to discuss. These items must be submitted at least 2 weeks prior to the scheduled meeting. Items must be submitted electronically as editable Microsoft word documents. Items must include: the person (or persons, committee, etc.) introducing the item and the date of submission. Items should be marked as informational items (board updates), discussion items (not asking for action), or action items. For action items, the specific action being requested by the board should be clearly indicated. Late items: From time to time, items of critical importance may need to be introduced within 2 weeks of the board meeting. These items will be marked in the board book as “Late” and will only be discussed after a majority vote of the board to discuss the item. Motions: Introducing a main motion 1) The chair may call on the person responsible for the next order of business. Or, when no one else has the floor, a board member may address the chair by proper title. After recognition by the chair, the board member may make a motion. 2) To make a motion, state, “I move that…,” and state your motion. For example, “I move that we discuss item #4 regarding updating our travel policy…” Regarding the above items of business, the person who introduced the item of business and who’s name appears on the item of business should introduce the motion. 3) Another member may second your motion. A second simply means that the motion should be discussed. If the motion is not seconded, it is not up for discussion. It is not lost, as there has been no vote. 4) Only if there is a second, the chair states “It has been moved and seconded that…” (state the motion). “Is there any discussion?” 5) Only one main motion may be on the floor at a time. Discussing a motion 1) All speaking points should be limited to 3 minutes. This will be enforced with a timer, and an OMA staff person will be designated to monitor the timer. A different time limit (or no time limit) may also be used if requested by a majority of the quorum, either for a single item of business, or for the entire meeting. 2) The member who made the motion is entitled to speak to it first. 3) Every member may speak to the motion. Only the motion at hand should be spoken either for or against. Each member should clearly state whether they are speaking for or against the motion. 4) A person may not speak against their own motion (however, they can vote against their own motion). 5) All discussion should be directed towards the motion. Avoid using a person’s name during the debate. 6) All questions should be directed to the chair. 7) Each member may only speak to the motion twice; however, asking a question or a brief suggestion does not count as that person’s debate.
Rules of Order Policy Board Approved September 2017
8) A person may only speak a third time with the chair’s permission. 9) Only the person who introduced the motion may speak again at the end (even if this is a third time). Voting on a motion 1) Before a vote is taken, the Chair puts the question to a vote by saying “Those in favor of the motion that… (repeat the motion) … say ‘Aye.’ Those opposed say ‘No.’” 2) Wait, then say “The motion is carried,” or “The motion is lost.” 3) If a member is in doubt about the result, he or she may call for “division.” A division is a demand for a standing vote count. This may be show of hands or ballot. 4) A majority is MORE than ½ of the votes cast by persons entitled to vote (a tie does NOT carry because it is not a majority). 5) A confidential written vote may be requested by any member of the board during in-person meetings. This would not require a second. Subsidiary Motions 1. Amending a motion a. Any main motion or resolution may be amended by: adding at the end, striking out or inserting words, substitution. b. To amend a motion, during discussion, a member may say “I move to amend the motion by…” Another member must second this amendment. c. The chair asks “Is there any discussion on the amendment? [repeat amendment].” At this point, only the amendment is discussed. d. When discussion ceases, the Chair says “Those in favor of the amendment [repeat amendment] say ‘Aye.’ Those opposed say ‘Nay.’ e. At this point, the motion carries or not. The main motion (amended or not) can now be voted on, discussion can continue, or the motion may be amended again (by another motion). f. Note, even if an amendment is passed, the main motion has still not been voted on – a separate vote is required. 2. Postpone definitely / indefinitely a. When the assembly does not want to take a position on the main question at all (indefinitely) b. When the assembly wants to delay to a certain time (definitely) 3. Motion to substitute a. When the assembly wishes to substitute a new motion for the original motion. 4. Refer a. Sends a pending motion to a committee, etc. 5. Limit debate / Extend debate 6. Lay the motion on the table (tabling the motion) a. This is used to lay the pending question aside and move on with other business. This may be appropriate when there is a more urgent question at hand, scheduling issue (people invited to speak to the board), etc. Privileged Motions 1. Call for order of the day – a member can interrupt a speaker to call for sticking with the agenda. 2. Recess – used to request an intermission (does not end the meeting)
Rules of Order Policy Board Approved September 2017
3. Adjourn – used to end the meeting. 4. Fix the time to Which to Adjourn – sets the time at which the meeting will adjourn; any unfinished business is moved to the next meeting. Incidental Motions 1. Point of order – used when member feels rules are being violated. Member may interrupt a speaker to raise a point of order. 2. Appeal – used to challenge the chair’s ruling. 3. Suspend the rules – example – suspend the time limit, allow other discussions, etc. 4. Withdraw – permits the maker of the motion to withdraw it. 5. Point of information – requests to the chair to provide information relevant to business at hand. A point of information must be in the form of a question. 6. Objection to consideration of a question – suppresses business that is irrelevant or inappropriate and undesirable to be discussed. Other Main Motions 1. Take from the table – resumes consideration of a motion laid on the table earlier. 2. Reconsider – reopens a motion to debate that has already been voted upon in the same session. 3. Rescind or amend – something previously adopted Other Rules of Conduct: 1. Be prepared – Carefully review the complete board manual before the board meeting. 2. Communicate prior to the meeting – Many items can be resolved before the meeting, saving valuable time. Or, big ticket items can be identified and proper time allocated. 3. Freedom of movement – Board members are welcome to stand, sit, or use the facilities as needed. 4. Freedom of opinion – Board members are free to express their opinions, without fear of stigmatization or personal attack by other board members. 5. Respect – Board members are expected to treat each other respectfully. 6. Attention – Board members are expected to pay attention. This requires turning off cell phones and other distracting electronic devices. Board members are expected not to be texting, emailing or making personal calls (barring emergency or urgent situations) during meetings. 7. Conflict of interest – If a real or perceived conflict exists, a board member must disclose this. Depending on the conflict, if the other board members feel the conflict is not germane to the item being discussed, the member may be allowed to discuss and vote. Other options – member may be allowed to discuss but not vote. Member may be not allowed to discuss or vote. Or, member may be asked to leave the board room for the discussion. The board should determine the level of conflict and appropriate level of involvement by the conflicted member on the issue at hand.
Conflict of Interest Policy and Disclosure Statement
OMA Conflict of Interest Policy The Obesity Medicine Association (OMA) Board of Trustees must act at all times in the best interest of OMA. The purpose of this policy is to help inform the OMA, its members and leaders about what constitutes a conflict of interest, provide assistance in identification and disclosure of actual and potential conflicts, and help ensure the avoidance and resolution of conflicts of interest when necessary. This policy may be enforced as described below: 1. Board members have a fiduciary duty to conduct themselves without conflict to the interests of OMA. In these capacities, they must subordinate personal, individual business, third-party and other interests to the welfare and best interests of OMA. 2. A conflict of interest is a transaction or relationship which presents or may present a conflict between an individual’s obligations to OMA and the individual’s personal, business or other interests. a. Generally, a conflict of interest could be said to exist when individuals have material interests outside OMA which could influence them, or could be perceived as influencing them to act contrary to the best interests of OMA and for their own personal benefit or the benefit of a relative or business associate. If such conflict is identified, the individual is asked to extract themselves from voting on a motion. b. Frequently the type of interest resulting in a conflict would be financial, such as an individual who has an association with a third party through ownership interest, stock/bond holdings, a grant, an employment relationship, or a consultative or advisory arrangement. Examples include serving on a speakers’ bureau or advisory board, as well as receiving honoraria from a medical education company for CME presentations. NOTE: An individual’s employment by a pharmaceutical company involved in obesity, medical device company involved in obesity, supplement or food company involved in weight loss products, or other companies that could have the appearance of having a conflict of interest with OMA as determined from time to time by the OMA Board of Trustees are deemed to be direct conflicts of interest that would preclude the individual from serving as a member of the OMA Board of Trustees. c. In some instances a conflict of interest may exist even though the conflict does not arise out of financial considerations. For example, a member of the OMA Board of Trustees also may have a fiduciary responsibility as a member of the Board of Trustees or committee of another organization. If the interests of that organization were contrary to or in competition with the interests of OMA, a situation could exist in which the individual could not fulfill his or her fiduciary responsibilities to both organizations or may be disqualified as a board of trustee candidate during the nomination process. 3. All conflicts of interest are not necessarily prohibited or harmful to the OMA. However, full disclosure of all actual and potential conflicts, and a determination by the Board – with the interested individual recused from participating in debates and voting on the matter – are required. NOTE: some conflicts may lead to a disqualification during candidacy as determined by the OMA Nominating Committee. 4. All actual and potential conflicts of interest shall be disclosed by Board members through the annual disclosure statement and/or whenever a conflict arises. The disinterested members of the Board shall make a determination as to whether a conflict exists and what subsequent action is appropriate (i.e. require the person with the conflict to abstain from discussing or voting on matters involving the conflict, resign from office, etc.). 5. On an annual basis, all Board members shall be provided with a copy of this policy and are required to complete and sign the disclosure statement below. OMA will provide all members of the Board with copies of the disclosure statements for all members of the Board and will publicly list potential conflicts as part of the candidacy announcement. Note: A separate policy exists for all OMA Continuing Medical Education activities. Individuals participating in these activities are subject to the “OMA Policy for Commercial Support and Continuing Education Programs” and should complete the full disclosure statement developed solely for these activities.
Disclosure Statement I have read the OMA conflict of interest policy set forth above and agree to comply fully with its terms and conditions at all times during my service to OMA. If at any time following submission of this form I become aware of any actual or potential conflicts of interest, or if the information provided below becomes inaccurate or incomplete, I will promptly notify the OMA Executive Director in writing. I understand that if I indicate a financial or other relationship or interest below, that information will be reviewed to determine whether this relationship precludes my participation on the Board. I understand that failure or refusal to disclose, false disclosure, or inability to resolve conflicts of interest will disqualify me from participating on the Board immediately. I agree that as an OMA Board of Trustee member I will make every effort that all my Association related activities and votes will be solely in the best interest of the OMA.
Disclosure of Actual or Potential Conflicts of Interest occurring within 1 year of the date of this form and within the foreseeable future:
Disclosure of ANY interests that could possibly result in a Conflict of Interest in the future with OMA, such as an ownership interest in any business, stock/bond holdings, a grant, an employment relationship, or consultative or advisory arrangement, etc.:
Disclosure of involvement / relationships with other similar or competitive associations / societies which represent interests of obesity medicine clinicians (please specify your level of involvement, i.e. board member, committee leader, committee member, general member, etc.):
Signature
Print Name
Date
Product
Company
Description
Type
Relationship
Board Member
CinRX is a biotech company founded in 2015 that is focused on the drug development sector.
Angela Fitch
Pharmaceuticals
Pharmaceutical
CinRX
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General
Advisory Board & Speakers Bureau
Pharmaceutical
Eli Lilly
Gelesis is a biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients. Knownwell Inc. is a healthcare delivery company Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Sidekick is a social health game. It is designed to motivate and engage people towards a healthy lifestyle. Sidekick allows people to communicate, collaborate and compete with friends and colleagues, while improving their lifestyle. Suvie builds a multi-zone cool to cook kitchen robot that makes 5 star meals with zero effort. Ms.Medicine is an innovative health care organization whose mission is to raise the standard of care of women’s health. Diet Program
Biotechnology, Medical Device, diabetes
Pharmaceuticals
Advisory Board
Gelesis
Pharmaceuticals
Biotechnology
Knownwell Inc.
Stock Ownership
Pharmaceuticals
Biotechnology, pharmaceutical
Merck
Editor
Pharmaceuticals
Biotechnology, pharmaceutical
NovoNordisk
Advisory Board
Biotechnology
Sidekick Health
Behavior App
Food and beverage
Science Advisory Board
Nutrition
Jenny Craig
Nutrition
Suvie
Food and beverage
Advisor
Turn-Key Business Solutions MsMedicine
Health Care
Advisory Board
FoundHealth.com offers information to help patients discover a range of treatments for their health challenges Health Care
Turn-Key Business Solutions Found Health
Advisory Board
This course covers critical topics in the prevention and treatment of obesity and related disorders presented by authorities from the country’s leading obesity treatment centers.
Harvard Blackburn Obesity Medicine
Education
Education
Co-Director
The American College of Physicians (ACP) is a national organization of internists, who specialize in the diagnosis, treatment, and care of adults Association
501C-6 / 501C-3 Organizations
American College of Physicians (ACP)
Member
The American Society for Metabolic and Bariatric Surgery (ASMBS) is the largest national society for this specialty. The vision of the Society is to improve public health and well being by lessening the burden of the disease of obesity and related diseases throughout the world. The Obesity Society (TOS) is the leading scientific society dedicated to the study of obesity.
American Society of Metabolic and Bariatric Surgery (ASMBS)
501C-6 / 501C-3 Organizations 501C-6 / 501C-3 Organizations
Association
Member
General Member, planning committee
The Obesity Society (TOS)
Association
Product
Company
Company Description
Type
Relationship
Board Member
Currax Pharmaceuticals LLC is a patient-first pharmaceutical company focused on the number one and number two preventable deaths in the United States: smoking addiction and obesity.
Ethan Lazarus
Pharmaceutical
Currax
Pharmaceutical
Speaker, Advisory Board
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General
Speaker, Advisory Board (May 18th and 19th 2023 for advisory board)
Pharmaceutical
Eli Lilly
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Rhythm Pharmaceuticals is a commercial-stage biopharmaceutical company committed to transforming the care for patients living with rare genetic diseases of obesity. Nestlé Health Science is a leader in the field of nutritional science, committed to redefining the management of health. We offer an extensive portfolio of science-based consumer health, medical nutrition and supplement brands. This course covers critical topics in the prevention and treatment of obesity and related disorders presented by authorities from the country’s leading obesity treatment centers. The American Academy of Family Physicians (AAFP) was founded in 1947 to promote and maintain high quality standards for family medicine, an offshoot of the classical general practitioner. The American Medical Association (AMA) is an organization of American physicians, the objective of which is “to promote the science and art of medicine and the betterment of public health.”
Pharmaceutical
NovoNordisk
Biotechnology, pharmaceutical
Speakers Bureau
Consultant in development of hyperphagia assessment tool
Pharmaceutical
Rhythm Pharmaceuticals
Biotechnology, pharmaceutical
Nutrition
Nestle Nutrition
Food and beverage
Advisory Board/Speaker
Harvard Blackburn Obesity Medicine
Education
Education
Presenter
501C-6 / 501C-3 Organizations
American Academy of Family Physicians
Member
Association
501C-6 / 501C-3 Organizations
American Medical Association (AMA)
Association
Member, Delegate for OMA
The Colorado Medical Society (CMS) is the largest group of organized physicians in Colorado. This nonprofit organization is
composed of physicians, residents and medical students. It was founded in 1871 to promote the art and science of medicine and to improve public health. Association
501C-6 / 501C-3 Organizations
Colorado Medical Society
Member
Boehringer Ingelheim is a pharmaceutical company that develops innovative healthcare products for both human & animal needs.
Biotechnology, Medical, Pharma ceutical
Pharmaceuticals
Advisory Board
Boehringer Ingelheim
Product
Company
Type
Relationship
Board Member
Company Description
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General
Lydia Alexander
Pharmaceutical
Speakers Bureau
Eli Lilly
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This course covers critical topics in the prevention and treatment of obesity and related disorders presented by authorities from the country’s leading obesity treatment centers. Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. The American Medical Association (AMA) is an organization of American physicians, the objective of which is “to promote the science and art of medicine and the betterment of public health.” The Obesity Society (TOS) is the leading scientific society dedicated to the study of obesity. The American College of Lifestyle Medicine (ACLM) is the medical professional society providing quality education and certification to those dedicated to clinical and worksite practice of lifestyle medicine as the foundation of a transformed and sustainable health care system. Intuitive Surgical, Inc. is an American corporation that develops, manufactures, and markets robotic products designed to improve clinical outcomes of patients through minimally invasive surgery, most notably with the da Vinci Surgical System. Enara Health is a holistic weight management platform that is building an expansive healthcare network to scale medical obesity treatment. 89bio is a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardio-metabolic diseases. Allergan plc is an American, Irish domiciled pharmaceutical company that acquires, develops, manufactures and markets brand name drugs and medical devices in the areas of medical aesthetics, eye care, central nervous system, and gastroenterology. Medical devices in major areas (e.g. cardiovascular, neurology, orthopedic) Minimally invasive – surgery technologies including robotics and tracking Medical equipment: therapeutic and diagnostic Health and personal Care products Medical IT and healthcare web applications Aesthetic-medical technologies Altimmune is a clinical-stage biopharmaceutical company focused on the development of novel peptide based therapeutics for the treatment of obesity and liver diseases. Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California Anji Pharma is a clinical-stage biotech company with operations in the U.S., Beijing, and Shanghai. Company Description
Pharmaceuticals
Biotechnology, pharmaceutical
Advisory Board
NovoNordisk
Harvard Blackburn Obesity Medicine
Obesity Medicine Course Lecturer
Education
Education
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General
Pharmaceutical
Eli Lilly
Speakers Bureau
SELECT Obesity National Advisory Board
Pharmaceuticals
Biotechnology, pharmaceutical
NovoNordisk
501C-6 / 501C-3 Organizations 501C-6 / 501C-3 Organizations
American Medical Association (AMA)
Association
Member
The Obesity Society (TOS)
Association
Member
The American College of Physicians (ACP) is a national organization of internists, who specialize in the diagnosis, treatment, and care of adults Association
501C-6 / 501C-3 Organizations
American College of Physicians (ACP)
Member
501C-6 / 501C-3 Organizations
American College of Lifestyle Medicine
Association
Member
Surgical
Intuitive Surgical
Corporation
Consultant
Biotechnology
Enara Health
Biotechnology platform
Stock Ownership
Product
Company
Type
Relationship
Board Member
Received Grant, Consultant/Advisor
Harold Bays
Pharmaceuticals
89Bio
Biopharmaceutical
Pharmaceuticals
Allergan
Pharmaceutical
Received Grant
Pharmaceuticals
Alon Medteck/Epitomee
Devices, therapeutics
Received Grant
Received Grant, Consultant/Advisor
Pharmaceuticals
Altimmune
Biopharmaceutical
Received Grant, Consultant/Advisor
Pharmaceuticals
Amgen
Biopharmaceutical
Pharmaceuticals
Anji Pharma
Biotech
Received Grant
AstraZeneca is a global, science-led biopharmaceutical company that focuses on the discovery, development and commercialization of prescription medicines. Axsome Therapeutics, Inc. is a biopharmaceutical company developing novel therapies for central nervous system (CNS) conditions that have limited treatment options. Biohaven is a clinical-stage biopharmaceutical company with proven leadership in industry and academic settings. Bionime was established in April 2003 with the goal of improving the lives of people with diabetes through better self-monitoring. Bionime is focused on designing and manufacturing accurate medical testing equipment. Boehringer Ingelheim is a pharmaceutical company that develops innovative healthcare products for both human & animal needs. CinCor is a clinical-stage biopharmaceutical company targeting cardiovascular, metabolic and kidney diseases CSL Behring is a biopharmaceutical company, manufacturing plasma derived and recombinant therapeutic products Esperion Therapeutics, Inc. is a public American pharmaceutical company focused on the development of bempedoic acid, an orally available small molecule designed to lower elevated levels of LDL-C. Evidera provides evidence-based solutions to demonstrate the real-world effectiveness, safety, and value of biopharmaceutical and biotechnology products A metabolic therapeutics company focused on pioneering new approaches for the treatment of metabolic diseases, including type 2 diabetes and obesity. Their goal is to transform metabolic disease treatment from chronic symptomatic management to durable disease-modifying therapies that target the organ-level root causes of T2D and obesity. Gan & Lee Pharmaceuticals is a leading pharmaceutical company in China specializing in the development, production, and commercialization of recombinant insulin analogs and injection pens,* with plans to expand globally. Kallyope, Inc. is a leading biotechnology company focused on identifying and developing therapeutics involving the gut-brain axis. Madrigal is a clinical-stage biopharmaceutical company pursuing novel therapeutics for fatty liver diseases. Matinas Biopharma Holdings, Inc. is a biopharmaceutical company. The Company is focused on redefining the intracellular delivery of nucleic acids and small molecules through its lipid nanocrystal (LNC) drug delivery platform. Merck & Co., Inc. is a global health care company. The Company offers health solutions through its prescription medicines, vaccines, biologic therapies and animal health products. NewAmsterdam Pharma is a clinical stage company focused on the research and development of transformative therapies for cardio-metabolic diseases.
Pharmaceuticals
Biopharmaceutical
AstraZeneca
Received Grant
Pharmaceuticals
Biopharmaceutical
Received Grant
Axsome
Pharmaceuticals
Biopharmaceutical
BioHaven
Received Grant
Pharmaceuticals
Biotechnology
Bionime
Received Grant
Biotechnology, Medical, Pharma ceutical
Received Grant, Consultant/advisor
Pharmaceuticals
Boehringer Ingelheim
Pharmaceutical
CinCor
Biopharmaceutical
Received Grant
Pharmaceutical
CSL Behring
Biopharmaceutical
Received Grant
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General
Received Grant, Consultant/advisor
Pharmaceutical
Eli Lilly
Received Grant, Consultant/Advisor
Pharmaceutical
Pharmaceutical
Esperion
Biopharmaceutical, biotechnology
Pharmaceutical
Received Grant
Evidera
Biopharmaceutical, biotechnology
Fractyl
Received Grant
Biotechnology
Pharmaceutical
Gan and Lee
Pharmaceutical
Received Grant
Biotechnology
Biotechnology
Received Grant
Kallyope
Pharmaceutical
Madrigal
Biopharmaceutical
Received Grant
Pharmaceutical
Matinas
Biopharmaceutical
Received Grant
Pharmaceutical
Merck
Biotechnology, pharmaceutical
Received Grant
Pharmaceutical
New Amsterdam
Pharmaceutical
Received Grant
Novartis AG is a Switzerland-based pharmaceutical company. The Company develops, manufactures, and markets branded and generic prescription drugs, active pharmaceutical ingredients (APIs), biosimilars and ophthalmic products. Pharmaceutical
Pharmaceutical
Novartis
Received Grant
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Pfizer is a pharmaceuticals and biotechnology company. Regerenron is a leading biotechnology company that invents life-transforming medicines for people with serious diseases
Pharmaceutical
NovoNordisk
Biotechnology, pharmaceutical
Received Grant
Pharmaceutical
Pfizer
Biotechnology, pharmaceutical
Received Grant
Pharmaceutical
Regerenron
Biotechnology
Received Grant
Sanofi S.A. is a French multinational pharmaceutical and healthcare company headquartered in Paris, France. We are a clinical-stage biopharmaceutical company dedicated to bringing novel treatments to people who suffer from migraine and other debilitating conditions. Selecta Biosciences is a clinical stage biotechnology company with a commitment to solving the challenges associated with autoimmunity and unwanted immunogenicity through our pioneering ImmTOR® precision immune tolerance platform. Shionogi Inc. is dedicated to advancing the greater good by developing, partnering, and commercializing medicine to treat serious unmet medical needs. a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, VIVUS, Inc. is a biopharmaceutical company developing therapies for obesity, sleep apnea, diabetes and sexual health. Metavante Technologies, Inc., through its subsidiary, Metavante Corporation, provided financial technology services, software and financial services regulatory advice and consulting to its customers, consisting primarily of small to large sized financial institutions. An Academic Research Organization of Brigham & Women's Hospital and An Affiliate of Harvard Medical School The Obesity Society (TOS) is the leading scientific society dedicated to the study of obesity. The ASPC, founded in 1985, represents a multidisciplinary group of healthcare practitioners and researchers who share an interest in and a passion for preventive cardiology. Endocrine Society is a global community of endocrine investigators and clinicians focused on improving patient care, advancing research, shaping effective policy, and ensuring the future of endocrinology. The American College of Cardiology, a 49,000-member nonprofit medical society, enhances the lives of cardiovascular patients through continuous quality improvement, patient-centered care, payment innovation, and professionalism. The ADA's mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. The National Lipid Association is a 501(c)(3) organization formed in 2008 to serve as a patient education organization in the field of clinical lipidology. The American Medical Association (AMA) is an organization of American physicians, the objective of which is “to promote the science and art of medicine and the betterment of public health.” World Obesity Federation is a membership organisation representing national and regional associations dedicated to the study and management of obesity and related comorbidities. This course covers critical topics in the prevention and treatment of obesity and related disorders presented by authorities from the country’s leading obesity treatment centers. An annual symposium, in honor of George A Bray MD, preeminent obesity experts from PBRC and around the US will elucidate the latest advances in the pathophysiology of obesity as well as advances in multidisciplinary obesity treatment. Home Access Health Corporation, which is now a subsidiary of Everly Practice Management Software
Pharmaceutical
Pharmaceutical
Sanofi
Received Grant
Pharmaceutical
Biopharmaceutical
Received Grant
Satsuma
Pharmaceutical
Biotechnology
Received Grant
Selecta
Pharmaceutical
Shionogi
Pharmaceutical company
Received Grant
Biopharmaceutical
Biopharmaceutical company Received Grant
Viking
Pharmaceutical
Vivus
Biopharmaceutical
Received Grant
Health, was founded to provide customers with health information through simple, self-collected lab tests Health Care
Laboratory Testing Legal Technology
Received Grant Received Grant
Home Access
Lexicon
Legal Technology
Technology
Metavant
Business Tools
Received Grant
501C-6 / 501C-3 Organizations 501C-6 / 501C-3 Organizations
TIMI
Education
Received Grant
General Member, Fellow, Speaker
The Obesity Society (TOS)
Association
The American Society of Preventative Cardiology (ASPC)
501C-6 / 501C-3 Organizations
Association
Board Member, Fellow, Speaker
501C-6 / 501C-3 Organizations
The Endocrine Society
Association
Member
AACE is the organization focused on endocrinology, diabetes and metabolism that is most: Recognized worldwide for its clinical leadership Association
American Association of Clinical Endocrinologists (AACE)
501C-6 / 501C-3 Organizations
Member
501C-6 / 501C-3 Organizations 501C-6 / 501C-3 Organizations
American College of Cardiology (ACC)
Association
Member, Fellow, Speaker
American Diabetes Association (ADA)
Association
Member
501C-6 / 501C-3 Organizations
The National Lipid Association
Association
Producing a Joint Statement
501C-6 / 501C-3 Organizations
American Medical Association (AMA)
Association
Member
501C-6 / 501C-3 Organizations
World Obesity Federation
Association
Member
Harvard Blackburn Obesity Medicine
Education
Education
Speaker
Bray Obesity Science Symposium (BOSS)
Education
Education
Speaker
Product
Company
Type
Relationship
Board Member
Company Description
Endocrine Society is a global community of endocrine investigators and clinicians focused on improving patient care, advancing research, shaping effective policy, and ensuring the future of endocrinology. The Pediatric Endocrine Society invites members to form Special Interest Groups (SIGs). SIGs provide a venue for members to network with other colleagues sharing similar interests, to provide a forum to discuss issues concerning topics relevant to the SIGs, and work towards goals that will benefit our patients and the membership of the Pediatric Endocrine Society at large. Currax Pharmaceuticals LLC is a patient-first pharmaceutical company focused on the number one and number two preventable deaths in the United States: smoking addiction and obesity. Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Phenomix is a drug discovery and development company building a portfolio of novel therapeutics for the treatment of major human diseases VIVUS, Inc. is a biopharmaceutical company developing therapies for obesity, sleep apnea, diabetes and sexual health. Nestlé Health Science is a leader in the field of nutritional science, committed to redefining the management of health. We offer an extensive portfolio of science-based consumer health, medical nutrition and supplement brands. Illinois Obesity Society is a group of health care professionals dedicated to improving the treatment of Obesity in Illinois. Company Description
501C-6 / 501C-3 Organization+A69s
Marisa Censani
The Endocrine Society
Association
Member
501C-6 / 501C-3 Organization+A69s
Pediatric Endocrine Society (SIG)
Member, completed a three-year term as co-chair
Association
Product
Company
Type
Relationship
Board Member
Anthony Auriemma
Pharmaceuticals
Currax
Pharmaceutical
Speakers Bureau
Pharmaceuticals
Biotechnology, pharmaceutical
Speakers Bureau
NovoNordisk
Pharmaceuticals
Phenomix
Biotechnology, pharmaceutical
Consulting
Pharmaceuticals
Vivus
Biopharmaceutical
Speaker Bureau
Nutrition
Nestle Nutrition
Food and beverage
Consulting
501C-6 / 501C-3 Organizations
Illinois Obesity Society
Association
Board of Trustee Member
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General
Pharmaceutical
Eli Lilly
Speakers Bureau
Product
Company
Type
Relationship
Board Member
Company Description
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General
Sandra Christensen
Pharmaceuticals
Eli Lilly
Advisory Board
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.
Pharmaceuticals
NovoNordisk
Biotechnology, pharmaceutical
Speakers Bureau
The Washington Obesity Society is a coalition dedicated to creating a community resource for providers in the growing field of obesity medicine. Association
501C-6 / 501C-3 Organization+A69s
Washington Obesity Society
Trustee
AANP empowers all NPs to advance accessible, person-centered, equitable, high-quality health care for diverse communities through practice, education, advocacy, research and leadership.
501C-6 / 501C-3 Organization+A69s
the American Association of Nurse Practitioners (AANP).
Association
Member, speaker
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General
Pharmaceutical
Eli Lilly
Speaker
Abbott Laboratories is an American multinational medical devices and health care company. AANP is the largest and only full service national professional membership organization for NPs of all specialties. Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Rhythm Pharmaceuticals is a commercial-stage biopharmaceutical company committed to transforming the care for patients living with rare genetic diseases of obesity. The American Academy of Pediatrics (AAP) and its member pediatricians dedicate their efforts and resources to the health, safety and well-being of infants, children, adolescents and young adults. The Obesity Society (TOS) is the leading scientific society dedicated to the study of obesity. Company Description
Technology
Abbott Laboratories
Medical Device Company
Advisory Board
American Association of Nurse Practitioners
Professional Organization
Association
Education Planner and Fellow
Product
Company
Type
Relationship
Board Member
Suzanne Cuda
Pharmaceutical
NovoNordisk
Biotechnology, pharmaceutical
Advisory Board
Pharmaceutical
Rhythm Pharmaceuticals
Biotechnology, pharmaceutical
Gold Faculty
501C-6 / 501C-3 Organization+A69s 501C-6 / 501C-3 Organization+A69s
American Academy of Pediatrics
Association
Member
General Member
The Obesity Society (TOS)
Association
Product
Company
Type
Relationship
Board Member
Company Description
Course and consulting business to help physicians start obesity medicine practices
Carolynn Francavilla Brown
Education
Weight Care Consulting
Health Care
Owner
The American Medical Association (AMA) is an organization of American physicians, the objective of which is “to promote the science and art of medicine and the betterment of public health.”
501C-6 / 501C-3 Organization+A69s
American Medical Association (AMA)
Governing Council for private practice physicians
Association
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General
Pharmaceutical
Eli Lilly
Speakers Bureau
Product
Company
Type
Relationship
Board Member Michelle Freshwater Board Member
Company Description
Product
Company
Type
Relationship
Company Description
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Product sales in obesity medicine practice Physicians.com strives to improve the quality of life through routine and affordable telemedical care with increased accessibility to pharmacutucal drugs by providing quality products at the most affordable price.
Sylvia Gonsahn-Bollie
Pharmaceuticals
Biotechnology, pharmaceutical
Consulting
NovoNordisk
Education
Health Care
Shaklee Corporation
Ambassador
Healthcare
Physicians.com
Health Care
Medical Director
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General
Executive Director of Clinical Research in obesity
Pharmaceutical
Eli Lilly
Type
Relationship
Product
Company
Company Description
Board Member
The Obesity Society (TOS) is the leading scientific society dedicated to the study of obesity.
501C-6 / 501C-3 Organizations
Bharti K. Shetye
The Obesity Society (TOS)
Association
Member
c
The American Society for Metabolic & Bariatric Surgery is a non-profit medical organization dedicated to metabolic and bariatric surgery, and obesity-related diseases and conditions Association
American Society for Metabolic & Bariatric Surgery (ASMBS)
501C-6 / 501C-3 Organizations
Member
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care.
Pharmaceuticals
Biotechnology, pharmaceutical
Consultant Agreement
NovoNordisk
Product
Company
Type
Relationship
Board Member
Company Description
Currax Pharmaceuticals LLC is a patient-first pharmaceutical company focused on the number one and number two preventable deaths in the United States: smoking addiction and obesity. Phenomix is a drug discovery and development company building a portfolio of novel therapeutics for the treatment of major human diseases. Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Medical educational company The American Medical Association (AMA) is an organization of American physicians, the objective of which is “to promote the science and art of medicine and the betterment of public health.” Hims & Hers Health, Inc. is an American telehealth company that sells prescription and over-the-counter drugs online, as well as personal care products
Craig Primack
Pharmaceuticals
Currax
Pharmaceutical
Speakers Bureau
Pharmaceuticals
Phenomix
Biotechnology, pharmaceutical
Advisor
Nutrition Education Education
Nestle Nutrition
Food and beverage
Co-Medical Director
Paradigm Pri-Med
Education
Faculty
Continuing medical education (CME) Education
CME Speaker
501C-6 / 501C-3 Organization+A69s
American Medical Association (AMA)
Association
Member
Senior Vice President of Weight Management
Pharmaceuticals
HIMS Company
Biotechnology
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General
Pharmaceutical
Eli Lilly (Zepbound)
Speakers Bureau
Product
Company
Type
Relationship
Board Member
Company Description
Eli Lilly and Company discovers, develops, manufactures, and markets pharmaceutical products worldwide Drug Manufacturers—General
Tiffany Lowe Clayton
Pharmaceutical
Eli Lilly
Speakers Bureau
Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Provides a modern-day health coach certification integrating physical nutrition, mental health, and spirituality.
Pharmaceuticals
NovoNordisk
Biotechnology, pharmaceutical
Speakers Bureau
Institute of Transformational Health and Wellness
Wellness consulting (No products sold)
Pharmaceuticals
Biotechnology, pharmaceutical
Right2obesitycare.Org
The Beginning of a Movement
The Obesity Bill of Rights was developed to drive change at every level of the healthcare delivery system so the more than 100 million adults with obesity can expect the same respect, attention and quality care as people with other chronic diseases. In support of this goal, the following organizations have signed on as supporting the Obesity Bill of Rights and the core requirements for people with obesity to receive person-centered, quality care: Academy of Nutrition and Dietetics Alliance for Aging Research Alliance for Women ’ s Health & Prevention American Association of Clinical Endocrinology American College of Occupational and Environmental Medicine American Gastroenterological Association American Liver Foundation American Medical Women ’ s Association
American Nurses Association American Society on Aging American Society for Nutrition Amputee Coalition Association of Black Cardiologists Association of Diabetes Care & Education Specialists Bias180 Black Women ’ s Health Imperative Choose Healthy Life ConscienHealth
Council on Black Health Defeat Malnutrition Today Gerontological Society of America Global Liver Institute
Haitian American Nurses Alliance International Health Equity Coalition for Chronic Disease HealthyWomen
Liver Coalition of San Diego Lupus Foundation of America
Made with FlippingBook Learn more on our blog